Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

E-ISSN： 2211-5579|3|3|219-225

ISSN： 2211-5579

Source： Current Psychopharmacology, Vol.3, Iss.3, 2014-12, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

By Dell’Osso Bernardo Allen Andrea Hollander Eric

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2727-2740

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

By Abudy Anat Juven-Wetzler Alzbeta Zohar Joseph

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 585-596

Adis International

Access to resources Recommend Favorite

Treating obsessive-compulsive disorder with serotonin reuptake inhibitors

By Koran L.M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 162-163

Elsevier

Access to resources Recommend Favorite

Aripiprazole augmentation in treatment-refractory obsessive–compulsive disorder

By Sarkar Rahul Klein Julia Krüger Stephanie

Psychopharmacology, Vol. 197, Iss. 4, 2008-05 ,pp. : 687-688

Springer Publishing Company

Access to resources Recommend Favorite